IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Review on Anxiety and Its Current Drug Treatment

Author: RITIKA SHARMA, DR. PRADEEP GOYAL
Abstract: Anxiety, stress and tension are absolutely habitual human feelings. Persistence of these feelings for a longer period will affects physical and mental health both. It is considered to be the major cause of disability in world. It comprises of post-traumatic stress disorder, obsessive compulsive disorder, generalized anxiety disorder, panic attacks, phobias as well as depression. The neurotransmitters involved in brain involves in anxiety include GABA, serotonin, nor-epinephrine and dopamine. The developed ethological animal models (behavioural) demonstrated the anxiolytic properties of neurotransmitters, with the help of various models neuropeptide receptor agonist and antagonists, the potency in human clinical samples has concluded. Anti-anxiety medicines are used to treat anxiety. These medicines act by decreasing brain activity to mitigate the symptoms of anxiety, apprehensiveness and improving sleep. Prolonged use of these agents can cause serious side-effects such as cholinergic symptoms, weight gain, paradoxil effects, disturbed sleep etc. Thus, urgent need for new antianxiety drugs is a global concern. Thus, the insistence of herbal medicines is expanding due to their immense role and therapeutic efficacy with minimum side effects.
Keyword: Neurotransmitters, Serotonin, Anxiety, Anxiolytic plants.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.086
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free